STABLIX Trademark

Trademark Overview

On Wednesday, May 28, 2025, a trademark application was filed for STABLIX with the United States Patent and Trademark Office. The USPTO has given the STABLIX trademark a serial number of 99206364. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 28, 2025. This trademark is owned by Stablix, Inc.. The STABLIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the restoration of protein stability and function; Pharmaceutical preparations comprising small molecules for stabilizing cellular proteins to restore normal function and treat disease; pharmaceutical preparations for targeted protein stabilization

Pharmaceutical products development of new small molecules aimed at stabilizing cellular proteins to restore normal function and treat disease; research and development of therapeutic modalities for treatment of diseases; research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; research and development services in the field of protein stabilization therapeutics
stablix

General Information

Serial Number99206364
Word MarkSTABLIX
Filing DateWednesday, May 28, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, May 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the restoration of protein stability and function; Pharmaceutical preparations comprising small molecules for stabilizing cellular proteins to restore normal function and treat disease; pharmaceutical preparations for targeted protein stabilization
Goods and ServicesPharmaceutical products development of new small molecules aimed at stabilizing cellular proteins to restore normal function and treat disease; research and development of therapeutic modalities for treatment of diseases; research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; research and development services in the field of protein stabilization therapeutics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 28, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameStablix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02215

Trademark Events

Event DateEvent Description
Wednesday, May 28, 2025NEW APPLICATION ENTERED
Wednesday, May 28, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

stablix pharmaceutical development treat research function preparations protein normal diseases restore